Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy (Q63578852)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy |
clinical trial |
Statements
Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy (English)
0 references
1 February 2016
0 references
2 January 2017
0 references
43
0 references
40 year
0 references
80 year
0 references